• 10–15% has disease-modifying effect and can lead to type 2 diabetes remission.
• Medications and/or metabolic surgery are effective additions to lifestyle and can improve glycaemia, remission and weight loss.
In the Look AHEAD study,2 intensive lifestyle intervention improved:
• Diabetes control and complications.
• Depression.
• Physical function.
• Health-related quality of life.
• Sleep apnoea.
• Incontinence.
• Brain structure.
• Measurements of multimorbidity, geriatric syndromes/frailty and disability-free life-years.
• >10% weight loss may be required for benefits in terms of cardiovascular disease, mortality and complications such as NASH.
Nutrition
• No single ratio of carbohydrates, proteins and fat that is optimal for everyone with type 2 diabetes. Aim for a net energy deficit that can be sustained for weight loss.
• Encourage individually selected eating patterns that include foods with health benefits, while minimising foods known to be harmful.
• Network meta-analysis compared nine dietary approaches and demonstrated HbA1c reductions of 5.1–9.0 mmol/mol with all approaches compared to control diets.3
• Greater glycaemic benefits with Mediterranean diet and low-carbohydrate diet (<26% energy from carbs), but low-carb benefits only demonstrated up to 6 months.4
• Systematic review of trials >6 months:5 compared to a low-fat diet, a Mediterranean diet showed greater reductions in weight and HbA1c levels, delayed requirements for diabetes medication and provided benefits for cardiovascular health. Similar benefits seen with vegan and vegetarian diets.
• 12-month study of intermittent fasting (5:2 diet) and continuous energy restriction (1200–1500 kcal diet) demonstrated similar glycaemic effects, and at 24 months both groups achieved 3.9 kg weight loss.6
24-hour physical behaviours recommended for type 2 diabetes
Sleep
• Over 50% people with type 2 diabetes have obstructive sleep apnoea; increase severity associated with worsening glucose levels.
• U-shaped curve of sleep and health outcomes: 6–8 hours optimal for HbA1c – improves insulin sensitivity and reduces energy intake.7
• Irregular sleep associated with poorer glycaemic control; catch-up weekend sleep does not reverse impact of insufficient sleep.8
• “Night owls”/evening chronotypes may be more prone to inactivity and poorer control than “early birds”/morning chronotypes.
Aerobic exercise (“Sweating”)
• Regular aerobic exercise can decrease HbA1c by 7 mmol/mol (0.6%) and improves cardiorespiratory fitness significantly; optimise with ≥45 minutes per session and especially post-prandial.9
• Encourage ≥150 minutes moderate to vigorous or ≥75 min vigorous, over ≥3 days per week; 30 min moderate/vigorous per week has metabolic benefit.
Stepping
• Additional 500 steps per day associated with 2–9% decreased risk cardiovascular disease morbidity and all-cause mortality.10
• 5–6 min brisk-intensity walk daily equates to/associated with around 4 years’ greater life expectancy.
Strengthening
• Resistance exercise improves insulin sensitivity and glucose levels.
• Encourage 2–3 resistance, balance, flexibility sessions per week.
• Physical function/frailty/sarcopenia can deteriorate faster in those with type 2 diabetes.
Sitting/breaking up prolonged sitting
• Limit sitting.
• Break up with walking or simple resistance exercise every 30 minutes.
1. Lingvay I, Sumithran P, Cohen RV, le Roux CW (2022) Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet399: 394–405
2. Wing RR; Look AHEAD research group (2021) Does lifestyle intervention improve health of adults with overweight/obesity and type 2 diabetes? findings from the Look AHEAD randomized trial. Obesity (Silver Spring)29: 1246–58
3. Schwingshackl L, Chaimani A, Hoffmann G et al (2018) A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol33: 157–70
4. Snorgaard O, Poulsen GM, Andersen HK, Astrup A (2017) Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care5: e000354
5. Martínez-González MA, Gea A, Ruiz-Canela M (2019) The Mediterranean diet and cardiovascular health. Circ Res124: 779–98
6. Carter S, Clifton PM, Keogh JB (2019) The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial. Diabetes Res Clin Pract151: 11–9
7. Lee SWH, Ng KY, Chin WK (2017) The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: a systematic review and meta-analysis. Sleep Med Rev31: 91–101
8. Delevatti RS, Bracht CG, Lisboa SDC et al (2019) The role of aerobic training variables progression on glycemic control of patients with type 2 diabetes: a systematic review with meta-analysis. Sports Med Open5: 22
9. Depner CM, Melanson EL, Eckel RH et al (2019) Ad libitum weekend recovery sleep fails to prevent metabolic dysregulation during a repeating pattern of insufficient sleep and weekend recovery sleep. Curr Biol29: 957–67
10. Saint-Maurice PF, Troiano RP, Bassett DR Jr et al (2020) Association of daily step count and step intensity with mortality among US adults. JAMA323: 1151–60
Free for all UK & Ireland healthcare professionals
Sign up to all DiabetesontheNet journals
By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.
Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.
We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.
Diabetes &
Primary Care
Issue:
Vol:24 | No:05
So what should we recommend to people with diabetes about lifestyle? Updated ADA/EASD advice
Weight loss of 5–15% as an important goal1
• 5–10% provides metabolic improvement.
• 10–15% has disease-modifying effect and can lead to type 2 diabetes remission.
• Medications and/or metabolic surgery are effective additions to lifestyle and can improve glycaemia, remission and weight loss.
In the Look AHEAD study,2 intensive lifestyle intervention improved:
• Diabetes control and complications.
• Depression.
• Physical function.
• Health-related quality of life.
• Sleep apnoea.
• Incontinence.
• Brain structure.
• Measurements of multimorbidity, geriatric syndromes/frailty and disability-free life-years.
• >10% weight loss may be required for benefits in terms of cardiovascular disease, mortality and complications such as NASH.
Nutrition
• No single ratio of carbohydrates, proteins and fat that is optimal for everyone with type 2 diabetes. Aim for a net energy deficit that can be sustained for weight loss.
• Encourage individually selected eating patterns that include foods with health benefits, while minimising foods known to be harmful.
• Network meta-analysis compared nine dietary approaches and demonstrated HbA1c reductions of 5.1–9.0 mmol/mol with all approaches compared to control diets.3
• Greater glycaemic benefits with Mediterranean diet and low-carbohydrate diet (<26% energy from carbs), but low-carb benefits only demonstrated up to 6 months.4
• Systematic review of trials >6 months:5 compared to a low-fat diet, a Mediterranean diet showed greater reductions in weight and HbA1c levels, delayed requirements for diabetes medication and provided benefits for cardiovascular health. Similar benefits seen with vegan and vegetarian diets.
• 12-month study of intermittent fasting (5:2 diet) and continuous energy restriction (1200–1500 kcal diet) demonstrated similar glycaemic effects, and at 24 months both groups achieved 3.9 kg weight loss.6
24-hour physical behaviours recommended for type 2 diabetes
Sleep
• Over 50% people with type 2 diabetes have obstructive sleep apnoea; increase severity associated with worsening glucose levels.
• U-shaped curve of sleep and health outcomes: 6–8 hours optimal for HbA1c – improves insulin sensitivity and reduces energy intake.7
• Irregular sleep associated with poorer glycaemic control; catch-up weekend sleep does not reverse impact of insufficient sleep.8
• “Night owls”/evening chronotypes may be more prone to inactivity and poorer control than “early birds”/morning chronotypes.
Aerobic exercise (“Sweating”)
• Regular aerobic exercise can decrease HbA1c by 7 mmol/mol (0.6%) and improves cardiorespiratory fitness significantly; optimise with ≥45 minutes per session and especially post-prandial.9
• Encourage ≥150 minutes moderate to vigorous or ≥75 min vigorous, over ≥3 days per week; 30 min moderate/vigorous per week has metabolic benefit.
Stepping
• Additional 500 steps per day associated with 2–9% decreased risk cardiovascular disease morbidity and all-cause mortality.10
• 5–6 min brisk-intensity walk daily equates to/associated with around 4 years’ greater life expectancy.
Strengthening
• Resistance exercise improves insulin sensitivity and glucose levels.
• Encourage 2–3 resistance, balance, flexibility sessions per week.
• Physical function/frailty/sarcopenia can deteriorate faster in those with type 2 diabetes.
Sitting/breaking up prolonged sitting
• Limit sitting.
• Break up with walking or simple resistance exercise every 30 minutes.
1. Lingvay I, Sumithran P, Cohen RV, le Roux CW (2022) Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet 399: 394–405
2. Wing RR; Look AHEAD research group (2021) Does lifestyle intervention improve health of adults with overweight/obesity and type 2 diabetes? findings from the Look AHEAD randomized trial. Obesity (Silver Spring) 29: 1246–58
3. Schwingshackl L, Chaimani A, Hoffmann G et al (2018) A network meta-analysis on the comparative efficacy of different dietary approaches on glycaemic control in patients with type 2 diabetes mellitus. Eur J Epidemiol 33: 157–70
4. Snorgaard O, Poulsen GM, Andersen HK, Astrup A (2017) Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes. BMJ Open Diabetes Res Care 5: e000354
5. Martínez-González MA, Gea A, Ruiz-Canela M (2019) The Mediterranean diet and cardiovascular health. Circ Res 124: 779–98
6. Carter S, Clifton PM, Keogh JB (2019) The effect of intermittent compared with continuous energy restriction on glycaemic control in patients with type 2 diabetes: 24-month follow-up of a randomised noninferiority trial. Diabetes Res Clin Pract 151: 11–9
7. Lee SWH, Ng KY, Chin WK (2017) The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: a systematic review and meta-analysis. Sleep Med Rev 31: 91–101
8. Delevatti RS, Bracht CG, Lisboa SDC et al (2019) The role of aerobic training variables progression on glycemic control of patients with type 2 diabetes: a systematic review with meta-analysis. Sports Med Open 5: 22
9. Depner CM, Melanson EL, Eckel RH et al (2019) Ad libitum weekend recovery sleep fails to prevent metabolic dysregulation during a repeating pattern of insufficient sleep and weekend recovery sleep. Curr Biol 29: 957–67
10. Saint-Maurice PF, Troiano RP, Bassett DR Jr et al (2020) Association of daily step count and step intensity with mortality among US adults. JAMA 323: 1151–60
Conference over coffee: New medicines, goals of triple therapy, AI prescribing, hypoglycaemia and lipids
Diabetes Distilled: Cardiovascular autonomic neuropathy – prevention, identification and management
Interactive case study: Managing acute illness in type 2 diabetes
Diabetes Distilled: ABCD–UKKA concise recommendations for management of CKD in type 2 diabetes
Welcome to the new PCDS Chair and Secretary
Conference over coffee: Diabetes and obesity initiatives, multiple long-term condition management and the bookends of pregnancy
Scottish Government and NHS Scotland consensus statement on GLP-1-based therapies for obesity
Key messages from the main sessions of the 2024 Scottish Conference of the Primary Care Diabetes Society to take back to our practice.
17 Dec 2024
What can we do in practice to reduce the risk of this common yet underdiagnosed microvascular complication of diabetes?
12 Dec 2024
Sick day rules and the prevention and identification of hyperglycaemic emergencies and acute kidney injury.
3 Dec 2024
Pragmatic recommendations for practising clinicians.
26 Nov 2024